1. Shupnik MA, Ridgway EC, Chin WW: Molecular biology of thyrotropin. Endocr Rev. 10: 459, 1989
2. Grossmann M, Weintraub BD, Szkudlinski MW: Novel insights into the molecular mechanisms of human thyrotropin action: structural, physiological, and therapeutic implications for the glycoprotein hormone family. Endocr Rev. 18: 476, 1997
3. Ridgway EC, Weintraub BD, Maloof F: Metabolic clearance and production rates of human thyrotropin. J Clin Invest. 53: 895, 1974
4. Kourides IA, Re RN, Weintraub BD, Ridgway EC, Maloof F: Metabolic clearance and secretion rates of subunits of human thyrotropin. J Clin Invest. 59: 508, 1977
5. Naylor SL, Chin WW, Goodman HM, Lalley PA, Grzeschik KH, Sakaguchi AY: Chromosome assignment of genes encoding the alpha and beta subunits of glycoprotein hormones in man and mouse. Somatic Cell Genet. 9: 757, 1983
6. Gordon DF, Wood WM, Ridgway EC: Organization and nucleotide sequence of the gene encoding the beta-subunit of murine thyrotropin. DNA. 7: 17, 1988
7. Burnside J, Buckland PR, Chin WW: Isolation and characterization of the gene encoding the alpha-subunit of the rat pituitary glycoprotein hormones. Gene. 70: 67, 1988
8. Carr FE, Need LR, Chin WW: Isolation and characterization of the rat thyrotropin beta-subunit gene. Differential regulation of two transcriptional start sites by thyroid hormone. J Biol Chem. 262: 981, 1987
9. Wondisford FE, Radovick S, Moates JM, Usala SJ, Weintraub BD: Isolation and characterization of the human thyrotropin beta-subunit gene. Differences in gene structure and promoter function from murine species. J Biol Chem. 263: 12538, 1988
10. Tatsumi K, Hayashizaki Y, Hiraoka Y, Miyai K, Matsubara K: The structure of the human thyrotropin beta-subunit gene. Gene. 73: 489, 1988
11. Magner JA: Thyroid-stimulating hormone: biosynthesis, cell biology, and bioactivity. Endocr Rev. 11: 354, 1990
12. Magner JA: Biosynthesis, cell biology, and bioactivity of thyroid-stimulating hormone: update 1994. In: Braverman L, Refetoff S, eds. Endocrine Reviews Monograph, vol 3. Rockville: The Endocrine Society, 1994; 55.
13. Weintraub BD, Stannard BS, Magner JA, Ronin C, et al.: Glycosylation and posttranslational processing of thyroid-stimulating hormone: clinical implications. Recent Prog Horm Res. 41: 577, 1985
14. Weintraub BD, Stannard BS, Linnekin D, Marshall M: Relationship of glycosylation to de novo thyroid-stimulating hormone biosynthesis and secretion by mouse pituitary tumor cells. J Biol Chem. 255: 5715, 1980
15. Szkudlinski MW, Teh NG, Grossmann M, Tropea JE, Weintraub BD: Engineering human glycoprotein hormone superactive analogues. Nat Biotechnol. 14: 1257, 1996
16. Amir SM, Kubota K, Tramontano D, Ingbar SH, Keutmann HT: The carbohydrate moiety of bovine thyrotropin is essential for full bioactivity but not for receptor recognition. Endocrinology. 120: 345, 1987
17. Menezes-Ferreira MM, Petrick PA, Weintraub BD: Regulation of thyrotropin (TSH) bioactivity by TSH-releasing hormone and thyroid hormone. Endocrinology. 118: 2125, 1986
18. Taylor T, Weintraub BD: Altered thyrotropin (TSH) carbohydrate structures in hypothalamic hypothyroidism created by paraventricular nuclear lesions are corrected by in vivo TSH-releasing hormone administration. Endocrinology. 125: 2198, 1989
19. Gesundheit N, Fink DL, Silverman LA, Weintraub BD: Effect of thyrotropin-releasing hormone on the carbohydrate structure of secreted mouse thyrotropin. Analysis by lectin affinity chromatography. J Biol Chem. 262: 5197, 1987
20. Petersen VB, McGregor AM, Belchetz PE, Elkeles RS, Hall R: The secretion of thyrotrophin with impaired biological activity in patients with hypothalamic-pituitary disease. Clin Endocrinol (Oxf). 8: 397, 1978
21. Faglia G, Bitensky L, Pinchera A, Ferrari C, et al.: Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab. 48: 989, 1979
22. Beck-Peccoz P, Amr S, Menezes-Ferreira MM, Faglia G, Weintraub BD: Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone. N Engl J Med. 312: 1085, 1985
23. Beck-Peccoz P, Persani L: Variable biological activity of thyroid-stimulating hormone. Eur J Endocrinol. 131: 331, 1994
24. Persani L, Terzolo M, Asteria C, Orlandi F, Angeli A, Beck-Peccoz P: Circadian variations of thyrotropin bioactivity in normal subjects and patients with primary hypothyroidism. J Clin Endocrinol Metab. 80: 2722, 1995
25. Persani L: Hypothalamic thyrotropin-releasing hormone and thyrotropin biological activity. Thyroid. 8: 941, 1998
26. Hayashizaki Y, Hiraoka Y, Endo Y, Miyai K, Matsubara K: Thyroid-stimulating hormone (TSH) deficiency caused by a single base substitution in the CAGYC region of the beta-subunit. Embo J. 8: 2291, 1989
27. Hayashizaki Y, Hiraoka Y, Tatsumi K, Hashimoto T, et al.: Deoxyribonucleic acid analyses of five families with familial inherited thyroid stimulating hormone deficiency. J Clin Endocrinol Metab. 71: 792, 1990
28. Dacou-Voutetakis C, Feltquate DM, Drakopoulou M, Kourides IA, Dracopoli NC: Familial hypothyroidism caused by a nonsense mutation in the thyroid-stimulating hormone beta-subunit gene. Am J Hum Genet. 46: 988, 1990
29. Medeiros-Neto G, Herodotou DT, Rajan S, Kommareddi S, et al.: A circulating, biologically inactive thyrotropin caused by a mutation in the beta subunit gene. J Clin Invest. 97: 1250, 1996
30. Doeker BM, Pfaffle RW, Pohlenz J, Andler W: Congenital central hypothyroidism due to a homozygous mutation in the thyrotropin beta-subunit gene follows an autosomal recessive inheritance. J Clin Endocrinol Metab. 83: 1762, 1998
31. Heinrichs C, Parma J, Scherberg NH, Delange F, et al.: Congenital central isolated hypothyroidism caused by a homozygous mutation in the TSH-beta subunit gene. Thyroid. 10: 387, 2000
32. Bonomi M, Proverbio MC, Weber G, Chiumello G, Beck-Peccoz P, Persani L: Hyperplastic pituitary gland, high serum glycoprotein hormone alpha- subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroidism due to mutations of the TSH beta gene. J Clin Endocrinol Metab. 86: 1600, 2001
33. Vallette-Kasic S, Barlier A, Teinturier C, Diaz A, et al.: PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab. 86: 4529, 2001
34. Pohlenz J, Dumitrescu A, Aumann U, Koch G, et al.: Congenital secondary hypothyroidism caused by exon skipping due to a homozygous donor splice site mutation in the TSHbeta-subunit gene. J Clin Endocrinol Metab. 87: 336, 2002
35. McDermott MT, Haugen BR, Black JN, Wood WM, Gordon DF, Ridgway EC: Congenital isolated central hypothyroidism caused by a "hot spot" mutation in the thyrotropin-beta gene. Thyroid. 12: 1141, 2002
36. Deladoey J, Vuissoz JM, Domene HM, Malik N, et al.: Congenital secondary hypothyroidism due to a mutation C105Vfs114X thyrotropin-beta mutation: genetic study of five unrelated families from Switzerland and Argentina. Thyroid. 13: 553, 2003
37. Azzam N, Bar-Shalom R, Kraiem Z, Fares F: Human thyrotropin (TSH) variants designed by site-directed mutagenesis block TSH activity in vitro and in vivo. Endocrinology. 146: 2845, 2005
38. Nakabayashi K, Matsumi H, Bhalla A, Bae J, et al.: Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor. J Clin Invest. 109: 1445, 2002
39. Wondisford FE: The thyroid axis just got more complicated. J Clin Invest. 109: 1401, 2002
40. Reichlin S, Utiger RD: Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma. J Clin Endocrinol Metab. 27: 251, 1967
41. Bogazzi F, Bartalena L, Brogioni S, Burelli A, et al.: L-thyroxine directly affects expression of thyroid hormone-sensitive genes: regulatory effect of RXRbeta. Mol Cell Endocrinol. 134: 23, 1997
42. Gurr JA, Kourides IA: Regulation of thyrotropin biosynthesis. Discordant effect of thyroid hormone on alpha and beta subunit mRNA levels. J Biol Chem. 258: 10208, 1983
43. Shupnik MA, Chin WW, Habener JF, Ridgway EC: Transcriptional regulation of the thyrotropin subunit genes by thyroid hormone. J Biol Chem. 260: 2900, 1985
44. Ridgway EC, Kourides IA, Chin WW, Cooper DS, Maloof F: Augmentation of pituitary thyrotrophin response to thyrotrophin releasing hormone during subphysiological tri-iodothyroinine therapy in hypothyroidism. Clin Endocrinol (Oxf). 10: 343, 1979
45. Chin WW, Carr FE, Burnside J, Darling DS: Thyroid hormone regulation of thyrotropin gene expression. Recent Prog Horm Res. 48: 393, 1993
46. Shupnik MA, Ridgway EC: Thyroid hormone control of thyrotropin gene expression in rat anterior pituitary cells. Endocrinology. 121: 619, 1987
47. Kourides IA, Gurr JA, Wolf O: The regulation and organization of thyroid stimulating hormone genes. Recent Prog Horm Res. 40: 79, 1984
48. Carr FE, Shupnik MA, Burnside J, Chin WW: Thyrotropin-releasing hormone stimulates the activity of the rat thyrotropin beta-subunit gene promoter transfected into pituitary cells. Mol Endocrinol. 3: 717, 1989
49. Carr FE, Ridgway EC, Chin WW: Rapid simultaneous measurement of rat alpha- and thyrotropin (TSH) beta-subunit messenger ribonucleic acids (mRNAs) by solution hybridization: regulation of TSH subunit mRNAs by thyroid hormones. Endocrinology. 117: 1272, 1985
50. Gurr JA, Januszeski MM, Tidikis IM, Norcross JJ, Kourides IA: Thyroid hormone regulates expression of the thyrotropin beta-subunit gene from both transcription start sites in the mouse and rat. Mol Cell Endocrinol. 71: 185, 1990
51. Chatterjee VK, Lee JK, Rentoumis A, Jameson JL: Negative regulation of the thyroid-stimulating hormone alpha gene by thyroid hormone: receptor interaction adjacent to the TATA box. Proc Natl Acad Sci U S A. 86: 9114, 1989
52. Wondisford FE, Farr EA, Radovick S, Steinfelder HJ, et al.: Thyroid hormone inhibition of human thyrotropin beta-subunit gene expression is mediated by a cis-acting element located in the first exon. J Biol Chem. 264: 14601, 1989
53. Bodenner DL, Mroczynski MA, Weintraub BD, Radovick S, Wondisford FE: A detailed functional and structural analysis of a major thyroid hormone inhibitory element in the human thyrotropin beta-subunit gene. J Biol Chem. 266: 21666, 1991
54. Darling DS, Burnside J, Chin WW: Binding of thyroid hormone receptors to the rat thyrotropin-beta gene. Mol Endocrinol. 3: 1359, 1989
55. Brent GA, Williams GR, Harney JW, Forman BM, et al.: Effects of varying the position of thyroid hormone response elements within the rat growth hormone promoter: implications for positive and negative regulation by 3,5,3'-triiodothyronine. Mol Endocrinol. 5: 542, 1991
56. Carr FE, Wong NC: Characteristics of a negative thyroid hormone response element. J Biol Chem. 269: 4175, 1994
57. Burnside J, Darling DS, Carr FE, Chin WW: Thyroid hormone regulation of the rat glycoprotein hormone alpha-subunit gene promoter activity. J Biol Chem. 264: 6886, 1989
58. Shupnik MA, Greenspan SL, Ridgway EC: Transcriptional regulation of thyrotropin subunit genes by thyrotropin-releasing hormone and dopamine in pituitary cell culture. J Biol Chem. 261: 12675, 1986
59. Langlois MF, Zanger K, Monden T, Safer JD, Hollenberg AN, Wondisford FE: A unique role of the beta-2 thyroid hormone receptor isoform in negative regulation by thyroid hormone. Mapping of a novel amino-terminal domain important for ligand-independent activation. J Biol Chem. 272: 24927, 1997
60. Wikstrom L, Johansson C, Salto C, Barlow C, et al.: Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1. Embo J. 17: 455, 1998
61. Forrest D, Hanebuth E, Smeyne RJ, Everds N, et al.: Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: evidence for tissue-specific modulation of receptor function. Embo J. 15: 3006, 1996
62. Weiss RE, Forrest D, Pohlenz J, Cua K, Curran T, Refetoff S: Thyrotropin regulation by thyroid hormone in thyroid hormone receptor beta-deficient mice. Endocrinology. 138: 3624, 1997
63. Abel ED, Boers ME, Pazos-Moura C, Moura E, et al.: Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system. J Clin Invest. 104: 291, 1999
64. Gothe S, Wang Z, Ng L, Kindblom JM, et al.: Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev. 13: 1329, 1999
65. Gauthier K, Chassande O, Plateroti M, Roux JP, et al.: Different functions for the thyroid hormone receptors TRalpha and TRbeta in the control of thyroid hormone production and post-natal development. Embo J. 18: 623, 1999
66. Hayashi Y, Xie J, Weiss RE, Pohlenz J, Refetoff S: Selective pituitary resistance to thyroid hormone produced by expression of a mutant thyroid hormone receptor beta gene in the pituitary gland of transgenic mice. Biochem Biophys Res Commun. 245: 204, 1998
67. Weiss RE, Chassande O, Koo EK, Macchia PE, et al.: Thyroid function and effect of aging in combined hetero/homozygous mice deficient in thyroid hormone receptors alpha and beta genes. J Endocrinol. 172: 177, 2002
68. Ando S, Sarlis NJ, Oldfield EH, Yen PM: Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab. 86: 5572, 2001
69. Abel ED, Moura EG, Ahima RS, Campos-Barros A, et al.: Dominant inhibition of thyroid hormone action selectively in the pituitary of thyroid hormone receptor-beta null mice abolishes the regulation of thyrotropin by thyroid hormone. Mol Endocrinol. 17: 1767, 2003
70. Zenke M, Munoz A, Sap J, Vennstrom B, Beug H: v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell. 61: 1035, 1990
71. Morita S, Fernandez-Mejia C, Melmed S: Retinoic acid selectively stimulates growth hormone secretion and messenger ribonucleic acid levels in rat pituitary cells. Endocrinology. 124: 2052, 1989
72. Wondisford FE, Steinfelder HJ, Nations M, Radovick S: AP-1 antagonizes thyroid hormone receptor action on the thyrotropin beta-subunit gene. J Biol Chem. 268: 2749, 1993
73. Shibusawa N, Hollenberg AN, Wondisford FE: Thyroid hormone receptor DNA binding is required for both positive and negative gene regulation. J Biol Chem. 278: 732, 2003
74. Nakano K, Matsushita A, Sasaki S, Misawa H, et al.: Thyroid-hormone-dependent negative regulation of thyrotropin beta gene by thyroid hormone receptors: study with a new experimental system using CV1 cells. Biochem J. 378: 549, 2004
75. Hallenbeck PL, Phyillaier M, Nikodem VM: Divergent effects of 9-cis-retinoic acid receptor on positive and negative thyroid hormone receptor-dependent gene expression. J Biol Chem. 268: 3825, 1993
76. Cohen O, Flynn TR, Wondisford FE: Ligand-dependent antagonism by retinoid X receptors of inhibitory thyroid hormone response elements. J Biol Chem. 270: 13899, 1995
77. Breen JJ, Hickok NJ, Gurr JA: The rat TSHbeta gene contains distinct response elements for regulation by retinoids and thyroid hormone. Mol Cell Endocrinol. 131: 137, 1997
78. Haugen BR, Brown NS, Wood WM, Gordon DF, Ridgway EC: The thyrotrope-restricted isoform of the retinoid-X receptor-gamma1 mediates 9-cis-retinoic acid suppression of thyrotropin-beta promoter activity. Mol Endocrinol. 11: 481, 1997
79. Flynn TR, Hollenberg AN, Cohen O, Menke JB, et al.: A novel C-terminal domain in the thyroid hormone receptor selectively mediates thyroid hormone inhibition. J Biol Chem. 269: 32713, 1994
80. Kim MK, McClaskey JH, Bodenner DL, Weintraub BD: A c-fos/c-jun-like factor and the pituitary-specific factor Pit-1 are both necessary to mediate induction of the human thyrotropin beta promoter. Trans Assoc Am Physicians. 106: 62, 1993
81. Pfahl M: Nuclear receptor/AP-1 interaction. Endocr Rev. 14: 651, 1993
82. Wondisford F, Magner J, Weintraub B: Thyrotropin. In: Braverman L, Utiger R, eds. Werner and Ingbars's The Thyroid - A Fundamental and Clinical Text. Philadelphia: Lippincott - Raven, 1996; p. 190.
83. Frankton S, Karmali R, Mirkine N, Bergmann P, Fuss M, Williams GR: Pituitary-thyroid feedback hypersensitivity as a novel cause of hypothyroidism in children. Lancet. 356: 1238, 2000
84. Koenig RJ, Watson AY: Enrichment of rat anterior pituitary cell types by metrizamide density gradient centrifugation. Endocrinology. 115: 317, 1984
85. Farquhar R, Rinehart J: Cytological alterations in the anterior pituitary gland following thyroidectomy. Endocrinology. 55: 857, 1954
86. Larsen PR, Silva JE, Kaplan MM: Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev. 2: 87, 1981
87. Chin WW, Shupnik MA, Ross DS, Habener JF, Ridgway EC: Regulation of the alpha and thyrotropin beta-subunit messenger ribonucleic acids by thyroid hormones. Endocrinology. 116: 873, 1985
88. Franklyn JA, Wood DF, Balfour NJ, Ramsden DB, et al.: Effect of hypothyroidism and thyroid hormone replacement in vivo on pituitary cytoplasmic concentrations of thyrotropin-beta and alpha-subunit messenger ribonucleic acids. Endocrinology. 120: 2279, 1987
89. Silva JE, Larsen PR: Pituitary nuclear 3,5,3'-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science. 198: 617, 1977
90. Vale W, Burgus R, Guillemin R: On the mechanism of action of TRF: effects of cycloheximide and actinomycin on the release of TSH stimulated in vitro by TRF and its inhibition by thyroxine. Neuroendocrinology. 3: 34, 1968
91. Bowers CY, Lee KL, Schally AV: A study on the interaction of the thyrotropin-releasing factor and L-triiodothyronine: effects of puromycin and cycloheximide. Endocrinology. 82: 75, 1968
92. Gard TG, Bernstein B, Larsen PR: Studies on the mechanism of 3,5,3'-triiodothyronine-induced suppression of secretagogue-induced thyrotropin release in vitro. Endocrinology. 108: 2046, 1981
93. Koenig RJ, Senator D, Larsen PR: Phorbol esters as probes of the regulation of thyrotropin secretion. Biochem Biophys Res Commun. 125: 353, 1984
94. Schrey MP, Larsen PR: Evidence for a possible role for Ca++ in the 3,5,3'-triiodothyronine inhibition of thyrotropin-releasing hormone-induced secretion of thyrotropin by rat anterior pituitary in vitro. Endocrinology. 108: 1690, 1981
95. Obregon MJ, Pascual A, Mallol J, Morreale de Escobar G, Escobar del Rey F: Evidence against a major role of L-thyroxine at the pituitary level: studies in rats treated with iopanoic acid (telepaque). Endocrinology. 106: 1827, 1980
96. Lueprasitsakul W, Alex S, Fang SL, Pino S, et al.: Flavonoid administration immediately displaces thyroxine (T4) from serum transthyretin, increases serum free T4, and decreases serum thyrotropin in the rat. Endocrinology. 126: 2890, 1990
97. Spencer CA, Takeuchi M, Kazarosyan M, MacKenzie F, Beckett GJ, Wilkinson E: Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH. Clin Chem. 41: 367, 1995
98. Riesco G, Taurog A, Larsen R, Krulich L: Acute and chronic responses to iodine deficiency in rats. Endocrinology. 100: 303, 1977
99. Patel YC, Pharoah PO, Hornabrook RW, Hetzel BS: Serum triiodothyronine, thyroxine and thyroid-stimulating hormone in endemic goiter: a comparison of goitrous and nongoitrous subjects in New Guinea. J Clin Endocrinol Metab. 37: 783, 1973
100. Wennlund A: Variation in serum levels of T3, T4, FT4 and TSH during thyroxine replacement therapy. Acta Endocrinol (Copenh). 113: 47, 1986
101. Bigos ST, Ridgway EC, Kourides IA, Maloof F: Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab. 46: 317, 1978
102. Jackson IM: Thyrotropin-releasing hormone. N Engl J Med. 306: 145, 1982
103. Guillemin R: Hypothalamic hormones a.k.a. hypothalamic releasing factors. J Endocrinol. 184: 11, 2005
104. Martino E, Lernmark A, Seo H, Steiner DF, Refetoff S: High concentration of thyrotropin-releasing hormone in pancreatic islets. Proc Natl Acad Sci U S A. 75: 4265, 1978
105. Gkonos PJ, Tavianini MA, Liu CC, Roos BA: Thyrotropin-releasing hormone gene expression in normal thyroid parafollicular cells. Mol Endocrinol. 3: 2101, 1989
106. Jeffcoate SL, White N, Hokfelt T, Fuxe K, Johansson O: Proceedings: Localization of thyrotrophin releasing hormone in the spinal cord of the rat by immunohisto-chemistry and radioimmunoassay. J Endocrinol. 69: 9P, 1976
107. Bruhn TO, Rondeel JM, Bolduc TG, Jackson IM: Thyrotropin-releasing hormone (TRH) gene expression in the anterior pituitary. I. Presence of pro-TRH messenger ribonucleic acid and pro-TRH-derived peptide in a subpopulation of somatotrophs. Endocrinology. 134: 815, 1994
108. Bilek R: TRH-like peptides in prostate gland and other tissues. Physiol Res. 49: S19, 2000
109. Bruhn TO, Huang SS, Vaslet C, Nillni EA: Glucocorticoids modulate the biosynthesis and processing of prothyrotropin releasing-hormone (proTRH). Endocrine. 9: 143, 1998
110. Bruhn TO, Rondeel JM, Jackson IM: Thyrotropin-releasing hormone gene expression in the anterior pituitary. IV. Evidence for paracrine and autocrine regulation. Endocrinology. 139: 3416, 1998
111. Yamada M, Wondisford FE, Radovick S, Nakayama Y, Weintraub BD, Wilber JF: Assignment of human preprothyrotropin-releasing hormone (TRH) gene to chromosome 3. Somat Cell Mol Genet. 17: 97, 1991
112. Yamada M, Radovick S, Wondisford FE, Nakayama Y, Weintraub BD, Wilber JF: Cloning and structure of human genomic DNA and hypothalamic cDNA encoding human prepro thyrotropin-releasing hormone. Mol Endocrinol. 4: 551, 1990
113. Lee SL, Stewart K, Goodman RH: Structure of the gene encoding rat thyrotropin releasing hormone. J Biol Chem. 263: 16604, 1988
114. Bulant M, Roussel JP, Astier H, Nicolas P, Vaudry H: Processing of thyrotropin-releasing hormone prohormone (pro-TRH) generates a biologically active peptide, prepro-TRH-(160-169), which regulates TRH-induced thyrotropin secretion. Proc Natl Acad Sci U S A. 87: 4439, 1990
115. Pekary AE: Is Ps4 (prepro-TRH [160-169]) more than an enhancer for thyrotropin-releasing hormone? Thyroid. 8: 963, 1998
116. Nillni EA, Sevarino KA: The biology of pro-thyrotropin-releasing hormone-derived peptides. Endocr Rev. 20: 599, 1999
117. Carr FE, Fein HG, Fisher CU, Wessendorf MW, Smallridge RC: A cryptic peptide (160-169) of thyrotropin-releasing hormone prohormone demonstrates biological activity in vivo and in vitro. Endocrinology. 131: 2653, 1992
118. Carr FE, Reid AH, Wessendorf MW: A cryptic peptide from the preprothyrotropin-releasing hormone precursor stimulates thyrotropin gene expression. Endocrinology. 133: 809, 1993
119. Jessop DS: Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. J Endocrinol. 160: 169, 1999
120. Engler D, Redei E, Kola I: The corticotropin-release inhibitory factor hypothesis: a review of the evidence for the existence of inhibitory as well as stimulatory hypophysiotropic regulation of adrenocorticotropin secretion and biosynthesis. Endocr Rev. 20: 460, 1999
121. Arimura A, Schally AV: Increase in basal and thyrotropin-releasing hormone (TRH)-stimulated secretion of thyrotropin (TSH) by passive immunization with antiserum to somatostatin in rats. Endocrinology. 98: 1069, 1976
122. Segerson TP, Kauer J, Wolfe HC, Mobtaker H, et al.: Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science. 238: 78, 1987
123. Koller KJ, Wolff RS, Warden MK, Zoeller RT: Thyroid hormones regulate levels of thyrotropin-releasing-hormone mRNA in the paraventricular nucleus. Proc Natl Acad Sci U S A. 84: 7329, 1987
124. Dyess EM, Segerson TP, Liposits Z, Paull WK, et al.: Triiodothyronine exerts direct cell-specific regulation of thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus. Endocrinology. 123: 2291, 1988
125. Kakucska I, Rand W, Lechan RM: Thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is dependent upon feedback regulation by both triiodothyronine and thyroxine. Endocrinology. 130: 2845, 1992
126. Strait KA, Zou L, Oppenheimer JH: Beta 1 isoform-specific regulation of a triiodothyronine-induced gene during cerebellar development. Mol Endocrinol. 6: 1874, 1992
127. Lechan RM, Qi Y, Jackson IM, Mahdavi V: Identification of thyroid hormone receptor isoforms in thyrotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus. Endocrinology. 135: 92, 1994
128. Wilber JF, Xu AH: The thyrotropin-releasing hormone gene 1998: cloning, characterization, and transcriptional regulation in the central nervous system, heart, and testis. Thyroid. 8: 897, 1998
129. Abel ED, Ahima RS, Boers ME, Elmquist JK, Wondisford FE: Critical role for thyroid hormone receptor beta2 in the regulation of paraventricular thyrotropin-releasing hormone neurons. J Clin Invest. 107: 1017, 2001
130. Riskind PN, Kolodny JM, Larsen PR: The regional hypothalamic distribution of type II 5'-monodeiodinase in euthyroid and hypothyroid rats. Brain Res. 420: 194, 1987
131. Dratman MB, Crutchfield FL: Synaptosomal [125I]triiodothyronine after intravenous [125I]thyroxine. Am J Physiol. 235: E638, 1978
132. Yamada M, Satoh T, Monden T, Mori M: Assignment of the thyrotropin-releasing hormone gene (TRH) to human chromosome 3q13.3-->q21 by in situ hybridization. Cytogenet Cell Genet. 87: 275, 1999
133. Feng P, Li QL, Satoh T, Wilber JF: Ligand (T3) dependent and independent effects of thyroid hormone receptors upon human TRH gene transcription in neuroblastoma cells. Biochem Biophys Res Commun. 200: 171, 1994
134. Li QL, Feng P, Koch C, Shi ZX, Wilber JF: Reversal of TR-T3 inhibition of the hTRH gene by excess TR ligand-binding domain: evidence for novel accessory protein. Thyroid. 6: 233, 1996
135. Li QL, Feng P, Satoh T, Shi ZX, et al.: Regulation of the human TRH (hTRH) gene by human thyroid hormone receptor beta 1 (hTR beta 1) mutants. Endocr Res. 23: 297, 1997
136. Satoh T, Yamada M, Iwasaki T, Mori M: Negative regulation of the gene for the preprothyrotropin-releasing hormone from the mouse by thyroid hormone requires additional factors in conjunction with thyroid hormone receptors. J Biol Chem. 271: 27919, 1996
137. Cintra A, Fuxe K, Wikstrom AC, Visser T, Gustafsson JA: Evidence for thyrotropin-releasing hormone and glucocorticoid receptor-immunoreactive neurons in various preoptic and hypothalamic nuclei of the male rat. Brain Res. 506: 139, 1990
138. Jackson IM: Thyrotropin-releasing hormone and corticotropin-releasing hormone--what's the message? Endocrinology. 136: 2793, 1995
139. Luo LG, Bruhn T, Jackson IM: Glucocorticoids stimulate thyrotropin-releasing hormone gene expression in cultured hypothalamic neurons. Endocrinology. 136: 4945, 1995
140. Redei E, Rittenhouse PA, Revskoy S, McGivern RF, Aird F: A novel endogenous corticotropin release inhibiting factor. Ann N Y Acad Sci. 840: 456, 1998
141. Nicholson WE, Orth DN: Preprothyrotropin-releasing hormone-(178-199) does not inhibit corticotropin release. Endocrinology. 137: 2171, 1996
142. Shibusawa N, Yamada M, Hirato J, Monden T, Satoh T, Mori M: Requirement of thyrotropin-releasing hormone for the postnatal functions of pituitary thyrotrophs: ontogeny study of congenital tertiary hypothyroidism in mice. Mol Endocrinol. 14: 137, 2000
143. Straub RE, Frech GC, Joho RH, Gershengorn MC: Expression cloning of a cDNA encoding the mouse pituitary thyrotropin-releasing hormone receptor. Proc Natl Acad Sci U S A. 87: 9514, 1990
144. Hinuma S, Hosoya M, Ogi K, Tanaka H, Nagai Y, Onda H: Molecular cloning and functional expression of a human thyrotropin-releasing hormone (TRH) receptor gene. Biochim Biophys Acta. 1219: 251, 1994
145. Bilek R, Starka L: The computer modelling of human TRH receptor, TRH and TRH-like peptides. Physiol Res. 54: 141, 2005
146. Collu R, Tang J, Castagne J, Lagace G, et al.: A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab. 82: 1561, 1997
147. Collu R: Genetic aspects of central hypothyroidism. J Endocrinol Invest. 23: 125, 2000
148. Gershengorn MC: Bihormonal regulation of the thyrotropin-releasing hormone receptor in mouse pituitary thyrotropic tumor cells in culture. J Clin Invest. 62: 937, 1978
149. Fujimoto J, Gershengorn MC: Evidence for dual regulation by protein kinases A and C of thyrotropin-releasing hormone receptor mRNA in GH3 cells. Endocrinology. 129: 3430, 1991
150. Brenner-Gati L, Gershengorn MC: Effects of thyrotropin-releasing hormone on phosphoinositides and cytoplasmic free calcium in thyrotropic pituitary cells. Endocrinology. 118: 163, 1986
151. Oron Y, Gillo B, Straub RE, Gershengorn MC: Mechanism of membrane electrical response to thyrotropin-releasing hormone in Xenopus oocytes injected with GH3 pituitary cell messenger ribonucleic acid. Mol Endocrinol. 1: 918, 1987
152. Gershengorn MC: Thyrotropin-releasing hormone action: mechanism of calcium-mediated stimulation of prolactin secretion. Recent Prog Horm Res. 41: 607, 1985
153. Heinflink M, Nussenzveig DR, Friedman AM, Gershengorn MC: Thyrotropin-releasing hormone receptor activation does not elevate intracellular cyclic adenosine 3',5'-monophosphate in cells expressing high levels of receptors. J Clin Endocrinol Metab. 79: 650, 1994
154. Martin TF: Thyrotropin-releasing hormone rapidly activates the phosphodiester hydrolysis of polyphosphoinositides in GH3 pituitary cells. Evidence for the role of a polyphosphoinositide-specific phospholipase C in hormone action. J Biol Chem. 258: 14816, 1983
155. Nelson EJ, Hinkle PM: Characteristics of the Ca2+ spike and oscillations induced by different doses of thyrotropin-releasing hormone (TRH) in individual pituitary cells and nonexcitable cells transfected with TRH receptor complementary deoxyribonucleic acid. Endocrinology. 135: 1084, 1994
156. Nelson EJ, Hinkle PM: Thyrotropin-releasing hormone activates Ca2+ efflux. Evidence suggesting that a plasma membrane Ca2+ pump is an effector for a G-protein-coupled Ca(2+)-mobilizing receptor. J Biol Chem. 269: 30854, 1994
157. Ashworth R, Hinkle PM: Thyrotropin-releasing hormone-induced intracellular calcium responses in individual rat lactotrophs and thyrotrophs. Endocrinology. 137: 5205, 1996
158. Carr FE, Burnside J, Chin WW: Thyroid hormones regulate rat thyrotropin beta gene promoter activity expressed in GH3 cells. Mol Endocrinol. 3: 709, 1989
159. Shupnik MA, Weck J, Hinkle PM: Thyrotropin (TSH)-releasing hormone stimulates TSH beta promoter activity by two distinct mechanisms involving calcium influx through L type Ca2+ channels and protein kinase C. Mol Endocrinol. 10: 90, 1996
160. Steinfelder HJ, Wondisford FE: Thyrotropin (TSH) beta-subunit gene expression--an example for the complex regulation of pituitary hormone genes. Exp Clin Endocrinol Diabetes. 105: 196, 1997
161. Steinfelder HJ, Hauser P, Nakayama Y, Radovick S, et al.: Thyrotropin-releasing hormone regulation of human TSHB expression: role of a pituitary-specific transcription factor (Pit-1/GHF-1) and potential interaction with a thyroid hormone-inhibitory element. Proc Natl Acad Sci U S A. 88: 3130, 1991
162. Weintraub BD, Wondisford FE, Farr EA, Steinfelder HJ, et al.: Pre-translational and post-translational regulation of TSH synthesis in normal and neoplastic thyrotrophs. Horm Res. 32: 22, 1989
163. Zanger K, Cohen LE, Hashimoto K, Radovick S, Wondisford FE: A novel mechanism for cyclic adenosine 3',5'-monophosphate regulation of gene expression by CREB-binding protein. Mol Endocrinol. 13: 268, 1999
164. Hashimoto K, Zanger K, Hollenberg AN, Cohen LE, Radovick S, Wondisford FE: cAMP response element-binding protein-binding protein mediates thyrotropin-releasing hormone signaling on thyrotropin subunit genes. J Biol Chem. 275: 33365, 2000
165. Heuer H, Schafer MK, Bauer K: The thyrotropin-releasing hormone-degrading ectoenzyme: the third element of the thyrotropin-releasing hormone-signaling system. Thyroid. 8: 915, 1998
166. Steinfelder HJ, Radovick S, Mroczynski MA, Hauser P, et al.: Role of a pituitary-specific transcription factor (pit-1/GHF-1) or a closely related protein in cAMP regulation of human thyrotropin-beta subunit gene expression. J Clin Invest. 89: 409, 1992
167. Steinfelder HJ, Radovick S, Wondisford FE: Hormonal regulation of the thyrotropin beta-subunit gene by phosphorylation of the pituitary-specific transcription factor Pit-1. Proc Natl Acad Sci U S A. 89: 5942, 1992
168. Howard PW, Maurer RA: Thyrotropin releasing hormone stimulates transient phosphorylation of the tissue-specific transcription factor, Pit-1. J Biol Chem. 269: 28662, 1994
169. Parks JS, Brown MR, Hurley DL, Phelps CJ, Wajnrajch MP: Heritable disorders of pituitary development. J Clin Endocrinol Metab. 84: 4362, 1999
170. Camper SA, Saunders TL, Katz RW, Reeves RH: The Pit-1 transcription factor gene is a candidate for the murine Snell dwarf mutation. Genomics. 8: 586, 1990
171. Li S, Crenshaw EB, 3rd, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG: Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature. 347: 528, 1990
172. Parks JS, Kinoshita EI, Pfaffle RW: Pit-1 and hypopituitarism. TEM. 4: 81, 1993
173. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE: A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science. 257: 1115, 1992
174. Pfaffle RW, DiMattia GE, Parks JS, Brown MR, et al.: Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science. 257: 1118, 1992
175. Tatsumi K, Miyai K, Notomi T, Kaibe K, et al.: Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet. 1: 56, 1992
176. Turton JP, Reynaud R, Mehta A, Torpiano J, et al.: Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. J Clin Endocrinol Metab. 90: 4762, 2005
177. Hashimoto Y, Cisternino M, Cohen LE: A novel nonsense mutation in the Pit-1 gene: evidence for a gene dosage effect. J Clin Endocrinol Metab. 88: 1241, 2003
178. Cohen LE, Wondisford FE, Radovick S: Role of Pit-1 in the gene expression of growth hormone, prolactin, and thyrotropin. Endocrinol Metab Clin North Am. 25: 523, 1996
179. Gordon DF, Haugen BR, Sarapura VD, Nelson AR, Wood WM, Ridgway EC: Analysis of Pit-1 in regulating mouse TSH beta promoter activity in thyrotropes. Mol Cell Endocrinol. 96: 75, 1993
180. Haugen BR, Wood WM, Gordon DF, Ridgway EC: A thyrotrope-specific variant of Pit-1 transactivates the thyrotropin beta promoter. J Biol Chem. 268: 20818, 1993
181. Haugen BR, Gordon DF, Nelson AR, Wood WM, Ridgway EC: The combination of Pit-1 and Pit-1T have a synergistic stimulatory effect on the thyrotropin beta-subunit promoter but not the growth hormone or prolactin promoters. Mol Endocrinol. 8: 1574, 1994
182. Haugen BR, McDermott MT, Gordon DF, Rupp CL, Wood WM, Ridgway EC: Determinants of thyrotrope-specific thyrotropin beta promoter activation. Cooperation of Pit-1 with another factor. J Biol Chem. 271: 385, 1996
183. Gordon DF, Lewis SR, Haugen BR, James RA, et al.: Pit-1 and GATA-2 interact and functionally cooperate to activate the thyrotropin beta-subunit promoter. J Biol Chem. 272: 24339, 1997
184. Bach I, Rhodes SJ, Pearse RV, 2nd, Heinzel T, et al.: P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci U S A. 92: 2720, 1995
185. Deladoey J, Fluck C, Buyukgebiz A, Kuhlmann BV, et al.: "Hot spot" in the PROP1 gene responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab. 84: 1645, 1999
186. Vieira TC, Dias da Silva MR, Cerutti JM, Brunner E, et al.: Familial combined pituitary hormone deficiency due to a novel mutation R99Q in the hot spot region of Prophet of Pit-1 presenting as constitutional growth delay. J Clin Endocrinol Metab. 88: 38, 2003
187. Re RN, Kourides IA, Ridgway EC, Weintraub BD, Maloof F: The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab. 43: 338, 1976
188. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD: Thyrotropin-secreting pituitary tumors. Endocr Rev. 17: 610, 1996
189. Ross DS, Ellis MF, Milbury P, Ridgway EC: A comparison of changes in plasma thyrotropin beta- and alpha-subunits, and mouse thyrotropic tumor thyrotropin beta- and alpha-subunit mRNA concentrations after in vivo dexamethasone or T3 administration. Metabolism. 36: 799, 1987
190. Coiro V, Volpi R, Cataldo S, Capretti L, et al.: Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRH. J Investig Med. 48: 133, 2000
191. Ahlquist JA, Franklyn JA, Wood DF, Balfour NJ, et al.: Hormonal regulation of thyrotrophin synthesis and secretion. Horm Metab Res Suppl. 17: 86, 1987
192. Glass CK, Holloway JM, Devary OV, Rosenfeld MG: The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell. 54: 313, 1988
193. Lamberts SW, Zuyderwijk J, den Holder F, van Koetsveld P, Hofland L: Studies on the conditions determining the inhibitory effect of somatostatin on adrenocorticotropin, prolactin and thyrotropin release by cultured rat pituitary cells. Neuroendocrinology. 50: 44, 1989
194. Weeke J, Hansen AP, Lundaek K: Inhibition by somatostatin of basal levels of serum thyrotropin (TSH) in normal men. J Clin Endocrinol Metab. 41: 168, 1975
195. Weeke J, Christensen SE, Hansen AP, Laurberg P, Lundbaek K: Somatostatin and the 24 h levels of serum TSH, T3, T4, and reverse T3 in normals, diabetics and patients treated for myxoedema. Acta Endocrinol (Copenh). 94: 30, 1980
196. Yang I, Woo J, Kim S, Kim J, Kim Y, Choi Y: Suppression of TRH-stimulated TSH secretion by glucose-induced hypothalamic somatostatin release. Horm Metab Res. 28: 553, 1996
197. Comi RJ, Gesundheit N, Murray L, Gorden P, Weintraub BD: Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N Engl J Med. 317: 12, 1987
198. Beck-Peccoz P, Mariotti S, Guillausseau PJ, Medri G, et al.: Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995. J Clin Endocrinol Metab. 68: 208, 1989
199. Reisine T, Bell GI: Molecular biology of somatostatin receptors. Endocr Rev. 16: 427, 1995
200. Nabekura J, Mizuno Y, Oomura Y: Inhibitory effect of somatostatin on vagal motoneurons in the rat brain stem in vitro. Am J Physiol. 256: C155, 1989
201. Nilsson T, Arkhammar P, Rorsman P, Berggren PO: Suppression of insulin release by galanin and somatostatin is mediated by a G-protein. An effect involving repolarization and reduction in cytoplasmic free Ca2+ concentration. J Biol Chem. 264: 973, 1989
202. De Groef B, Goris N, Arckens L, Kuhn ER, Darras VM: Corticotropin-Releasing Hormone (CRH)-Induced Thyrotropin Release is Directly Mediated Through CRH Receptor Type 2 on Thyrotropes. Endocrinology. 144: 5537, 2003
203. De Groef B, Geris KL, Manzano J, Bernal J, et al.: Involvement of thyrotropin-releasing hormone receptor, somatostatin receptor subtype 2 and corticotropin-releasing hormone receptor type 1 in the control of chicken thyrotropin secretion. Mol Cell Endocrinol. 203: 33, 2003
204. Kennedy AR, Todd JF, Stanley SA, Abbott CR, et al.: Melanin-concentrating hormone (MCH) suppresses thyroid stimulating hormone (TSH) release, in vivo and in vitro, via the hypothalamus and the pituitary. Endocrinology. 142: 3265, 2000
205. Fukuda H, Greer MA: The effect of basal hypothalamic deafferentation on the nycthemeral rhythm of plasma TSH. Endocrinology. 97: 749, 1975
206. Spaulding SW, Burrow GN, Donabedian R, van Woert M: L-DOPA suppression of thyrotropin-releasing hormone response in man. J Clin Endocrinol Metab. 35: 182, 1972
207. Besses GS, Burrow GN, Spaulding SW, Donabedian RK: Dopamine infusion acutely inhibits the TSH and prolactin response to TRH. J Clin Endocrinol Metab. 41: 985, 1975
208. Leebaw WF, Lee LA, Woolf PD: Dopamine affects basal and augmented pituitary hormone secretion. J Clin Endocrinol Metab. 47: 480, 1978
209. Lewis BM, Dieguez C, Lewis MD, Scanlon MF: Dopamine stimulates release of thyrotrophin-releasing hormone from perfused intact rat hypothalamus via hypothalamic D2-receptors. J Endocrinol. 115: 419, 1987
210. Lewis B, Dieguez C, Ham J: Effects of glucose on TRH, GHRH, somatostatin and LHRH release from rat hypothalamus in vitro. J Neuroendocrinol. 1: 437, 1989
211. Krulich L, Giachetti A, Marchlewska-Koj A, Hefco E, Jameson HE: On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat. Endocrinology. 100: 496, 1977
212. Krulich L, Mayfield MA, Steele MK, McMillen BA, McCann SM, Koenig JI: Differential effects of pharmacological manipulations of central alpha 1- and alpha 2-adrenergic receptors on the secretion of thyrotropin and growth hormone in male rats. Endocrinology. 110: 796, 1982
213. Gershengorn MC, Rebecchi MJ, Geras E, Arevalo CO: Thyrotropin-releasing hormone (TRH) action in mouse thyrotropic tumor cells in culture: evidence against a role for adenosine 3',5'-monophosphate as a mediator of TRH-stimulated thyrotropin release. Endocrinology. 107: 665, 1980
214. Dieguez C, Foord SM, Peters JR, Hall R, Scanlon MF: Alpha 1-adrenoreceptors and alpha 1-adrenoreceptor-mediated thyrotropin release in cultures of euthyroid and hypothyroid rat anterior pituitary cells. Endocrinology. 117: 624, 1985
215. Sharp B, Morley JE, Carlson HE, Gordon J, et al.: The role of opiates and endogenous opioid peptides in the regulation of rat TSH secretion. Brain Res. 219: 335, 1981
216. Samuels MH, Kramer P, Wilson D, Sexton G: Effects of naloxone infusions on pulsatile thyrotropin secretion. J Clin Endocrinol Metab. 78: 1249, 1994
217. Peuranen E, Vasar E, Koks S, Volke V, et al.: Further studies on the role of cholecystokinin-A and B receptors in secretion of anterior pituitary hormones in male rats. Neuropeptides. 28: 1, 1995
218. Santos CV, Pazos-Moura CC, Moura EG: Effect of gastrin-releasing peptide (GRP) and GRP antagonists on TSH secretion from rat isolated pituitaries. Life Sci. 57: 911, 1995
219. Fekete C, Kelly J, Mihaly E, Sarkar S, et al.: Neuropeptide Y has a central inhibitory action on the hypothalamic- pituitary-thyroid axis. Endocrinology. 142: 2606, 2001
220. Ciosek J, Stempniak B: The influence of vasopressin or oxytocin on thyroid-stimulating hormone and thyroid hormones' concentrations in blood plasma of euthyroid rats. J Physiol Pharmacol. 48: 813, 1997
221. Beak SA, Small CJ, Ilovaiskaia I, Hurley JD, et al.: Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on alpha-TSH cells. Endocrinology. 137: 4130, 1996
222. Arvat E, Gianotti L, Ramunni J, Grottoli S, et al.: Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans. Eur J Endocrinol. 133: 300, 1995
223. Nillni EA, Vaslet C, Harris M, Hollenberg A, Bjorbak C, Flier JS: Leptin regulates prothyrotropin-releasing hormone biosynthesis. Evidence for direct and indirect pathways. J Biol Chem. 275: 36124, 2000
224. Seoane LM, Carro E, Tovar S, Casanueva FF, Dieguez C: Regulation of in vivo TSH secretion by leptin. Regul Pept. 92: 25, 2000
225. Flier JS, Harris M, Hollenberg AN: Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring. J Clin Invest. 105: 859, 2000
226. Ozawa M, Sato K, Han DC, Kawakami M, Tsushima T, Shizume K: Effects of tumor necrosis factor-alpha/cachectin on thyroid hormone metabolism in mice. Endocrinology. 123: 1461, 1988
227. Pang XP, Hershman JM, Mirell CJ, Pekary AE: Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-alpha (cachectin). Endocrinology. 125: 76, 1989
228. Dubuis JM, Dayer JM, Siegrist-Kaiser CA, Burger AG: Human recombinant interleukin-1 beta decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats. Endocrinology. 123: 2175, 1988
229. van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP: Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab. 71: 1567, 1990
230. Wassen FW, Moerings EP, Van Toor H, De Vrey EA, Hennemann G, Everts ME: Effects of interleukin-1 beta on thyrotropin secretion and thyroid hormone uptake in cultured rat anterior pituitary cells. Endocrinology. 137: 1591, 1996
231. Melmed S: gp130-related cytokines and their receptors in the pituitary. TEM. 9: 155, 1998
232. Rettori V, Dees WL, Hiney JK, Lyson K, McCann SM: An interleukin-1-alpha-like neuronal system in the preoptic-hypothalamic region and its induction by bacterial lipopolysaccharide in concentrations which alter pituitary hormone release. Neuroimmunomodulation. 1: 251, 1994
233. Koenig JI, Snow K, Clark BD, Toni R, et al.: Intrinsic pituitary interleukin-1 beta is induced by bacterial lipopolysaccharide. Endocrinology. 126: 3053, 1990
234. van Haasteren GA, van der Meer MJ, Hermus AR, Linkels E, et al.: Different effects of continuous infusion of interleukin-1 and interleukin-6 on the hypothalamic-hypophysial-thyroid axis. Endocrinology. 135: 1336, 1994
235. Bartalena L, Grasso L, Brogioni S, Martino E: Interleukin 6 effects on the pituitary-thyroid axis in the rat. Eur J Endocrinol. 131: 302, 1994
236. Kakucska I, Romero LI, Clark BD, Rondeel JM, et al.: Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-beta in the rat: implications for nonthyroidal illness. Neuroendocrinology. 59: 129, 1994
237. Baur A, Bauer K, Jarry H, Kohrle J: Effects of proinflammatory cytokines on anterior pituitary 5'- deiodinase type I and type II. J Endocrinol. 167: 505, 2000
238. Spangelo BL, MacLeod RM, Isakson PC: Production of interleukin-6 by anterior pituitary cells in vitro. Endocrinology. 126: 582, 1990
239. Vankelecom H, Carmeliet P, Van Damme J, Billiau A, Denef C: Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology. 49: 102, 1989
240. Prummel MF, Brokken LJ, Wiersinga WM: Ultra short-loop feedback control of thyrotropin secretion. Thyroid. 14: 825, 2004
241. Bockmann J, Winter C, Wittkowski W, Kreutz MR, Bockers TM: Cloning and expression of a brain-derived TSH receptor. Biochem Biophys Res Commun. 238: 173, 1997
242. Crisanti P, Omri B, Hughes E, Meduri G, et al.: The expression of thyrotropin receptor in the brain. Endocrinology. 142: 812, 2001
243. Prummel MF, Brokken LJ, Meduri G, Misrahi M, Bakker O, Wiersinga WM: Expression of the thyroid-stimulating hormone receptor in the folliculo- stellate cells of the human anterior pituitary. J Clin Endocrinol Metab. 85: 4347, 2000
244. Kourides IA, Ridgway EC, Weintraub BD, Bigos ST, Gershengorn MC, Maloof F: Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identify patients with pituitary tumors. J Clin Endocrinol Metab. 45: 534, 1977
245. Gesundheit N, Petrick PA, Nissim M, Dahlberg PA, et al.: Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med. 111: 827, 1989
246. Faglia G, Beck-Peccoz P, Piscitelli G, Medri G: Inappropriate secretion of thyrotropin by the pituitary. Horm Res. 26: 79, 1987
247. Spencer CA, Lai-Rosenfeld AO, Guttler RB, LoPresti J, et al.: Thyrotropin secretion in thyrotoxic and thyroxine-treated patients: assessment by a sensitive immunoenzymometric assay. J Clin Endocrinol Metab. 63: 349, 1986
248. Spencer CA, LoPresti JS, Patel A, Guttler RB, et al.: Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab. 70: 453, 1990
249. Spencer CA, Schwarzbein D, Guttler RB, LoPresti JS, Nicoloff JT: Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays. J Clin Endocrinol Metab. 76: 494, 1993
250. Greenspan SL, Klibanski A, Schoenfeld D, Ridgway EC: Pulsatile secretion of thyrotropin in man. J Clin Endocrinol Metab. 63: 661, 1986
251. Brabant G, Brabant A, Ranft U, Ocran K, et al.: Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J Clin Endocrinol Metab. 65: 83, 1987
252. Brabant G, Prank K, Ranft U, Schuermeyer T, et al.: Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J Clin Endocrinol Metab. 70: 403, 1990
253. Samuels MH, Veldhuis J, Ridgway EC: Copulsatile release of thyrotropin and prolactin in normal and hypothyroid subjects. Thyroid. 5: 369, 1995
254. Weeke J: Circadian variation of the serum thyrotropin level in normal subjects. Scand J Clin Lab Invest. 31: 337, 1973
255. Bartalena L, Martino E, Brandi LS, Falcone M, et al.: Lack of nocturnal serum thyrotropin surge after surgery. J Clin Endocrinol Metab. 70: 293, 1990
256. Parker DC, Pekary AE, Hershman JM: Effect of normal and reversed sleep-wake cycles upon nyctohemeral rhythmicity of plasma thyrotropin: evidence suggestive of an inhibitory influence in sleep. J Clin Endocrinol Metab. 43: 318, 1976
257. Parker DC, Rossman LG, Pekary AE, Hershman JM: Effect of 64-hour sleep deprivation on the circadian waveform of thyrotropin (TSH): further evidence of sleep-related inhibition of TSH release. J Clin Endocrinol Metab. 64: 157, 1987
258. Behrends J, Prank K, Dogu E, Brabant G: Central nervous system control of thyrotropin secretion during sleep and wakefulness. Horm Res. 49: 173, 1998
259. Hirshberg B, Veldhuis JD, Sarlis NJ: Diurnal thyrotropin secretion in short-term profound primary hypothyroidism: does it ever persist? Thyroid. 10: 1101, 2000
260. Mariotti S, Franceschi C, Cossarizza A, Pinchera A: The aging thyroid. Endocr Rev. 16: 686, 1995
261. Olsen T, Laurberg P, Weeke J: Low serum triiodothyronine and high serum reverse triiodothyronine in old age: an effect of disease not age. J Clin Endocrinol Metab. 47: 1111, 1978
262. Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PW, Hershman JM: Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med. 151: 165, 1991
263. Sawin CT, Geller A, Wolf PA, Belanger AJ, et al.: Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 331: 1249, 1994
264. Mariotti S, Barbesino G, Caturegli P, Bartalena L, et al.: Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab. 77: 1130, 1993
265. Cuttelod S, Lemarchand-Beraud T, Magnenat P, Perret C, Poli S, Vannotti A: Effect of age and role of kidneys and liver on thyrotropin turnover in man. Metabolism. 23: 101, 1974
266. van Coevorden A, Laurent E, Decoster C, Kerkhofs M, et al.: Decreased basal and stimulated thyrotropin secretion in healthy elderly men. J Clin Endocrinol Metab. 69: 177, 1989
267. Balsam A, Ingbar SH: Observations on the factors that control the generation of triiodothyronine from thyroxine in rat liver and the nature of the defect induced by fasting. J Clin Invest. 63: 1145, 1979
268. Harris AR, Fang SL, Hinerfeld L, Braverman LE, Vagenakis AG: The role of sulfhydryl groups on the impaired hepatic 3',3,5-triiodothyronine generation from thyroxine in the hypothyroid, starved, fetal, and neonatal rodent. J Clin Invest. 63: 516, 1979
269. Kaplan MM: Subcellular alterations causing reduced hepatic thyroxine-5'-monodeiodinase activity in fasted fats. Endocrinology. 104: 58, 1979
270. Kaplan MM, Tatro JB, Breitbart R, Larsen PR: Comparison of thyroxine and 3,3',5'-triiodothyronine metabolism in rat kidney and liver homogenates. Metabolism. 28: 1139, 1979
271. Kinlaw WB, Schwartz HL, Oppenheimer JH: Decreased serum triiodothyronine in starving rats is due primarily to diminished thyroidal secretion of thyroxine. J Clin Invest. 75: 1238, 1985
272. Wartofsky L, Burman KD: Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocr Rev. 3: 164, 1982
273. Wehmann RE, Gregerman RI, Burns WH, Saral R, Santos GW: Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. N Engl J Med. 312: 546, 1985
274. Hugues JN, Burger AG, Pekary AE, Hershman JM: Rapid adaptations of serum thyrotrophin, triiodothyronine and reverse triiodothyronine levels to short-term starvation and refeeding. Acta Endocrinol (Copenh). 105: 194, 1984
275. Samuels MH, Kramer P: Differential effects of short-term fasting on pulsatile thyrotropin, gonadotropin, and alpha-subunit secretion in healthy men--a clinical research center study. J Clin Endocrinol Metab. 81: 32, 1996
276. Samuels MH, Kramer P: Effects of metoclopramide on fasting-induced TSH suppression. Thyroid. 6: 85, 1996
277. Carlson HE, Drenick EJ, Chopra IJ, Hershman JM: Alterations in basal and TRH-stimulated serum levels of thyrotropin, prolactin, and thyroid hormones in starved obese men. J Clin Endocrinol Metab. 45: 707, 1977
278. Spencer CA, Lum SM, Wilber JF, Kaptein EM, Nicoloff JT: Dynamics of serum thyrotropin and thyroid hormone changes in fasting. J Clin Endocrinol Metab. 56: 883, 1983
279. Shi ZX, Levy A, Lightman SL: The effect of dietary protein on thyrotropin-releasing hormone and thyrotropin gene expression. Brain Res. 606: 1, 1993
280. Blake NG, Eckland DJ, Foster OJ, Lightman SL: Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation. Endocrinology. 129: 2714, 1991
281. Hugues JN, Enjalbert A, Moyse E, Shu C, et al.: Differential effects of passive immunization with somatostatin antiserum on adenohypophysial hormone secretions in starved rats. J Endocrinol. 109: 169, 1986
282. Kok P, Roelfsema F, Langendonk JG, Frolich M, et al.: High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab. 90: 4659, 2005
283. Kok P, Roelfsema F, Frolich M, Meinders AE, Pijl H: Spontaneous Diurnal Tsh Secretion Is Enhanced in Proportion to Circulating Leptin in Obese Premenopausal Women. J Clin Endocrinol Metab.:, 2005
284. Legradi G, Emerson CH, Ahima RS, Flier JS, Lechan RM: Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology. 138: 2569, 1997
285. Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, et al.: Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest. 107: 111, 2001
286. Kim MS, Small CJ, Stanley SA, Morgan DG, et al.: The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest. 105: 1005, 2000
287. Guo F, Bakal K, Minokoshi Y, Hollenberg AN: Leptin signaling targets the thyrotropin-releasing hormone gene promoter in vivo. Endocrinology. 145: 2221, 2004
288. Huo L, Munzberg H, Nillni EA, Bjorbaek C: Role of signal transducer and activator of transcription 3 in regulation of hypothalamic trh gene expression by leptin. Endocrinology. 145: 2516, 2004
289. Fekete C, Legradi G, Mihaly E, Huang QH, et al.: alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J Neurosci. 20: 1550, 2000
290. Mihaly E, Fekete C, Tatro JB, Liposits Z, Stopa EG, Lechan RM: Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone. J Clin Endocrinol Metab. 85: 2596, 2000
291. Fekete C, Marks DL, Sarkar S, Emerson CH, et al.: Effect of Agouti-related protein in regulation of the hypothalamic-pituitary-thyroid axis in the melanocortin 4 receptor knockout mouse. Endocrinology. 145: 4816, 2004
292. Fekete C, Sarkar S, Rand WM, Harney JW, et al.: Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis. Endocrinology. 143: 4513, 2002
293. Wittmann G, Liposits Z, Lechan RM, Fekete C: Medullary adrenergic neurons contribute to the neuropeptide Y-ergic innervation of hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the rat. Neurosci Lett. 324: 69, 2002
294. Kaplan MM, Larsen PR, Crantz FR, Dzau VJ, Rossing TH, Haddow JE: Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. Am J Med. 72: 9, 1982
295. Romijn JA, Adriaanse R, Brabant G, Prank K, Endert E, Wiersinga WM: Pulsatile secretion of thyrotropin during fasting: a decrease of thyrotropin pulse amplitude. J Clin Endocrinol Metab. 70: 1631, 1990
296. Kamat V, Hecht WL, Rubin RT: Influence of meal composition on the postprandial response of the pituitary-thyroid axis. Eur J Endocrinol. 133: 75, 1995
297. Oppert JM, Dussault JH, Tremblay A, Despres JP, Theriault G, Bouchard C: Thyroid hormones and thyrotropin variations during long term overfeeding in identical twins. J Clin Endocrinol Metab. 79: 547, 1994
298. Knudsen N, Laurberg P, Rasmussen LB, Bulow I, et al.: Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 90: 4019, 2005
299. Ehrmann DA, Weinberg M, Sarne DH: Limitations to the use of a sensitive assay for serum thyrotropin in the assessment of thyroid status. Arch Intern Med. 149: 369, 1989
300. Faber J, Kirkegaard C, Rasmussen B, Westh H, Busch-Sorensen M, Jensen IW: Pituitary-thyroid axis in critical illness. J Clin Endocrinol Metab. 65: 315, 1987
301. Hamblin PS, Dyer SA, Mohr VS, Le Grand BA, et al.: Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab. 62: 717, 1986
302. Romijn JA, Wiersinga WM: Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J Clin Endocrinol Metab. 70: 35, 1990
303. Custro N, Scafidi V, Gallo S, Notarbartolo A: Deficient pulsatile thyrotropin secretion in the low-thyroid-hormone state of severe non-thyroidal illness. Eur J Endocrinol. 130: 132, 1994
304. Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, et al.: Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues. Clin Endocrinol (Oxf). 47: 599, 1997
305. Bacci V, Schussler GC, Kaplan TB: The relationship between serum triiodothyronine and thyrotropin during systemic illness. J Clin Endocrinol Metab. 54: 1229, 1982
306. Brent GA, Hershman JM, Braunstein GD: Patients with severe nonthyroidal illness and serum thyrotropin concentrations in the hypothyroid range. Am J Med. 81: 463, 1986
307. Magner J, Roy P, Fainter L, Barnard V, Fletcher P, Jr.: Transiently decreased sialylation of thyrotropin (TSH) in a patient with the euthyroid sick syndrome. Thyroid. 7: 55, 1997
308. De Groot LJ: Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab. 84: 151, 1999
309. Fliers E, Alkemade A, Wiersinga WM: The hypothalamic-pituitary-thyroid axis in critical illness. Best Pract Res Clin Endocrinol Metab. 15: 453, 2001
310. Hennessey J, Jackson IMD: The interface between thyroid hormones and psychiatry. The endocrinologist. 6: 214, 1996
311. Bartalena L, Placidi GF, Martino E, Falcone M, et al.: Nocturnal serum thyrotropin (TSH) surge and the TSH response to TSH-releasing hormone: dissociated behavior in untreated depressives. J Clin Endocrinol Metab. 71: 650, 1990
312. Gold MS, Pottash AL, Extein I, Martin DM, et al.: The TRH test in the diagnosis of major and minor depression. Psychoneuroendocrinology. 6: 159, 1981
313. Chopra IJ, Solomon DH, Huang TS: Serum thyrotropin in hospitalized psychiatric patients: evidence for hyperthyrotropinemia as measured by an ultrasensitive thyrotropin assay. Metabolism. 39: 538, 1990
314. Loosen PT: Thyroid function in affective disorders and alcoholism. Endocrinol Metab Clin North Am. 17: 55, 1988
315. Banki CM, Bissette G, Arato M, Nemeroff CB: Elevation of immunoreactive CSF TRH in depressed patients. Am J Psychiatry. 145: 1526, 1988
316. Kirkegaard C, Carroll BJ: Dissociation of TSH adrenocortical disturbances in endogenous depression. Psychiatry Res. 3: 253, 1980
317. O'Shanick GJ, Ellinwood EH, Jr.: Persistent elevation of thyroid-stimulating hormone in women with bipolar affective disorder. Am J Psychiatry. 139: 513, 1982
318. Fliers E, Guldenaar SE, Wiersinga WM, Swaab DF: Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab. 82: 4032, 1997
319. Delitala G, Tomasi P, Virdis R: Prolactin, growth hormone and thyrotropin-thyroid hormone secretion during stress states in man. Baillieres Clin Endocrinol Metab. 1: 391, 1987
320. Chopra IJ, Sakane S, Teco GN: A study of the serum concentration of tumor necrosis factor-alpha in thyroidal and nonthyroidal illnesses. J Clin Endocrinol Metab. 72: 1113, 1991
321. Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM: Association between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab. 77: 1695, 1993
322. Murai H, Murakami S, Ishida K, Sugawara M: Elevated serum interleukin-6 and decreased thyroid hormone levels in postoperative patients and effects of IL-6 on thyroid cell function in vitro. Thyroid. 6: 601, 1996
323. Davies PH, Black EG, Sheppard MC, Franklyn JA: Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness. Clin Endocrinol (Oxf). 44: 199, 1996
324. Hermus RM, Sweep CG, van der Meer MJ, Ross HA, et al.: Continuous infusion of interleukin-1 beta induces a nonthyroidal illness syndrome in the rat. Endocrinology. 131: 2139, 1992
325. Sweep CG, van der Meer MJ, Ross HA, Vranckx R, Visser TJ, Hermus AR: Chronic infusion of TNF-alpha reduces plasma T4 binding without affecting pituitary-thyroid activity in rats. Am J Physiol. 263: E1099, 1992
326. Bartalena L, Brogioni S, Grasso L, Martino E: Interleukin-6 and the thyroid. Eur J Endocrinol. 132: 386, 1995
327. Kaptein EM, Spencer CA, Kamiel MB, Nicoloff JT: Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects. J Clin Endocrinol Metab. 51: 387, 1980
328. Duick DS, Wahner HW: Thyroid axis in patients with Cushing's syndrome. Arch Intern Med. 139: 767, 1979
329. Nicoloff JT, Fisher DA, Appleman MD, Jr.: The role of glucocorticoids in the regulation of thyroid function in man. J Clin Invest. 49: 1922, 1970
330. Alkemade A, Unmehopa UA, Wiersinga WM, Swaab DF, Fliers E: Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. J Clin Endocrinol Metab. 90: 323, 2005
331. Gharib H, Hodgson SF, Gastineau CF, Scholz DA, Smith LA: Reversible hypothyroidism in Addison's disease. Lancet. 2: 734, 1972
332. Topliss DJ, White EL, Stockigt JR: Significance of thyrotropin excess in untreated primary adrenal insufficiency. J Clin Endocrinol Metab. 50: 52, 1980
333. Surks MI, Sievert R: Drugs and thyroid function. N Engl J Med. 333: 1688, 1995
334. Faglia G, Beck-Peccoz P, Ferrari C, Ambrosi B, Spada A, Travaglini P: Enhanced plasma thyrotrophin response to thyrotrophin-releasing hormone following oestradiol administration in man. Clin Endocrinol (Oxf). 2: 207, 1973
335. Gershengorn MC, Marcus-Samuels BE, Geras E: Estrogens increase the number of thyrotropin-releasing hormone receptors on mammotropic cells in culture. Endocrinology. 105: 171, 1979
336. Morley JE, Sawin CT, Carlson HE, Longcope C, Hershman JM: The relationship of androgen to the thyrotropin and prolactin responses to thyrotropin-releasing hormone in hypogonadal and normal men. J Clin Endocrinol Metab. 52: 173, 1981
337. Arafah BM: Decreased levothyroxine requirement in women with hypothyroidism during androgen therapy for breast cancer. Ann Intern Med. 121: 247, 1994
338. Lippe BM, Van Herle AJ, LaFranchi SH, Uller RP, Lavin N, Kaplan SA: Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone. J Clin Endocrinol Metab. 40: 612, 1975
339. Porter BA, Refetoff S, Rosenfeld RL, De Groat LJ, Lang US, Stark O: Abnormal thyroxine metabolism in hyposomatotrophic dwarfism and inhibition of responsiveness to TRH during GH therapy. Pediatrics. 51: 668, 1973
340. Jorgensen JO, Pedersen SA, Laurberg P, Weeke J, Skakkebaek NE, Christiansen JS: Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. J Clin Endocrinol Metab. 69: 1127, 1989
341. Trainer PJ, Holly J, Medbak S, Rees LH, Besser GM: The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers. Clin Endocrinol (Oxf). 41: 801, 1994
342. Little KY, Garbutt JC, Mayo JP, Mason G: Lack of acute d-amphetamine effects on thyrotropin release. Neuroendocrinology. 48: 304, 1988
343. Rogol AD, Reeves GD, Varma MM, Blizzard RM: Thyroid-stimulating hormone and prolactin responses to thyrotropin-releasing hormone during infusion of epinephrine and propranolol in man. Neuroendocrinology. 29: 413, 1979
344. Zgliczynski S, Kaniewski M: Evidence for alpha-adrenergic receptors mediated TSH release in men. Acta Endocrinol (Copenh). 95: 172, 1980
345. Valcavi R, Dieguez C, Azzarito C, Artioli C, Portioli I, Scanlon MF: Alpha-adrenoreceptor blockade with thymoxamine reduces basal thyrotrophin levels but does not influence circadian thyrotrophin changes in man. J Endocrinol. 115: 187, 1987
346. Lotti G, Delitala G, Devilla L, Alagna S, Masala A: Reduction of plasma triiodothyronine (T3) induced by propranolol. Clin Endocrinol (Oxf). 6: 405, 1977
347. Plosker SM, Rabinovici J, Montalvo M, Jaffe RB: Endogenous catecholamines suppress thyrotropin secretion during the early follicular phase of the menstrual cycle. J Clin Endocrinol Metab. 80: 2530, 1995
348. Hay ID, Bayer MF, Kaplan MM, Klee GG, Larsen PR, Spencer CA: American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. The Committee on Nomenclature of the American Thyroid Association. Clin Chem. 37: 2002, 1991
349. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, et al.: Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 13: 3, 2003
350. Toft AD: Use of sensitive immunoradiometric assay for thyrotropin in clinical practice. Mayo Clin Proc. 63: 1035, 1988
351. Martino E, Bambini G, Bartalena L, Mammoli C, et al.: Human serum thyrotrophin measurement by ultrasensitive immunoradiometric assay as a first-line test in the evaluation of thyroid function. Clin Endocrinol (Oxf). 24: 141, 1986
352. Snyder PJ, Utiger RD: Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab. 34: 380, 1972
353. Faglia G: The clinical impact of the thyrotropin-releasing hormone test. Thyroid. 8: 903, 1998
354. Sawin CT, Hershman JM, Chopra IJ: The comparative effect of T4 and T3 on the TSH response to TRH in young adult men. J Clin Endocrinol Metab. 44: 273, 1977
355. Faglia G, Beck-Peccoz P, Ferrari C, Ambrosi B, et al.: Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. J Clin Endocrinol Metab. 37: 595, 1973
356. Mehta A, Hindmarsh PC, Stanhope RG, Brain CE, Preece MA, Dattani MT: Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. J Clin Endocrinol Metab. 88: 5696, 2003
357. Borst GC, Osburne RC, O'Brian JT, Georges LP, Burman KD: Fasting decreases thyrotropin responsiveness to thyrotropin-releasing hormone: a potential cause of misinterpretation of thyroid function tests in the critically ill. J Clin Endocrinol Metab. 57: 380, 1983
358. Gow SM, Elder A, Caldwell G, Bell G, et al.: An improved approach to thyroid function testing in patients with non-thyroidal illness. Clin Chim Acta. 158: 49, 1986
359. Franklyn JA, Black EG, Betteridge J, Sheppard MC: Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illness. J Clin Endocrinol Metab. 78: 1368, 1994
360. Toft AD, Irvine WJ, Hunter WM, Ratcliffe JG, Seth J: Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis. J Clin Endocrinol Metab. 39: 607, 1974
361. Toft AD, Irvine WJ, McIntosh D, Seth J, Cameron EH, Lidgard GP: Temporary hypothyroidism after surgical treatment of thyrotoxicosis. Lancet. 2: 817, 1976
362. Thein-Wai W, Larsen PR: Effects of weekly thyroxine administration on serum thyroxine, 3,5,3'-triiodothyronine, thyrotropin, and the thyrotropin response to thyrotropin-releasing hormone. J Clin Endocrinol Metab. 50: 560, 1980
363. Vagenakis AG, Braverman LE, Azizi F, Portinay GI, Ingbar SH: Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy. N Engl J Med. 293: 681, 1975
364. Coya R, Carro E, Mallo F, Dieguez C: Retinoic acid inhibits in vivo thyroid-stimulating hormone secretion. Life Sci. 60: 247, 1997
365. Sherman SI, Gopal J, Haugen BR, Chiu AC, et al.: Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med. 340: 1075, 1999
366. Gow SM, Kellett HA, Seth J, Sweeting VM, Toft AD, Beckett GJ: Limitations of new thyroid function tests in pregnancy. Clin Chim Acta. 152: 325, 1985
367. Emerson CH, Dysno WL, Utiger RD: Serum thyrotropin and thyroxine concentrations in patients recieving lithium carbonate. J Clin Endocrinol Metab. 36: 338, 1973
368. Refetoff S, Sunthornthepvarakul T, Gottschalk ME, Hayashi Y: Resistance to thyrotropin and other abnormalities of the thyrotropin receptor. Recent Prog Horm Res. 51: 97, 1996
369. Abramowicz MJ, Duprez L, Parma J, Vassart G, Heinrichs C: Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest. 99: 3018, 1997
370. Xie J, Pannain S, Pohlenz J, Weiss RE, et al.: Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH [see comments]. J Clin Endocrinol Metab. 82: 3933, 1997
371. Ahlbom BD, Yaqoob M, Larsson A, Ilicki A, Anneren G, Wadelius C: Genetic and linkage analysis of familial congenital hypothyroidism: exclusion of linkage to the TSH receptor gene. Hum Genet. 99: 186, 1997
372. Boscato LM, Stuart MC: Heterophilic antibodies: a problem for all immunoassays. Clin Chem. 34: 27, 1988
373. Despres N, Grant AM: Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem. 44: 440, 1998
374. Silva JE, Larsen PR: Peripheral metabolism of homologous thyrotropin in euthyroid and hypothyroid rats: acute effects of thyrotropin-releasing hormone, triiodothyronine, and thyroxine. Endocrinology. 102: 1783, 1978